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Introduction 1 
INTRODUCTION 
 
One of the main targets of current biochemical research is a molecular understanding 
of the function of biological membranes, one of the most important structures in the living 
systems. Membranes form a boundary between many of the quasi-independent systems which 
biochemists try to isolate and study. Cells, for example, are bounded by membranes, nutrients 
and waste products pass through, and the sites at which cells can be recognized by other cells 
and by small molecules are situated on the cell membrane. 
 
The cell organelles of eukaryotic cells, - the nuclei, mitochondria, endoplasmic 
reticulum and others – are bounded by membranes, each with its characteristic function. A 
cell which is divided into compartments by membranes is able to control its activity in a most 
sophisticated way. It becomes possible for the different compartments to contain different 
concentrations of metabolites. The asymmetric distribution of small molecules that can result 
allows the development of energy-conservation devices such as mitochondria and 
chloroplasts. Processes within the individual compartments can be controlled separately, 
leading to a greater efficiency in energy production and utilisation. Membranes also provide 
an apolar matrix within which the synthesis of water-insoluble compounds such as cholesterol 
can take place. 
 
The basic components of membranes are well known. Apart from the rigid cell wall 
structures in plants and many micro-organisms, the main membrane components are protein 
and lipid. Many types of lipid molecules are known, and they all have one basic chemical 
property in common: they are all soluble in organic solvent mixtures (commonly a mixture of 
chloroform and methanol is used) and insoluble in water. This water immiscibility is due to 
the high hydrocarbon content of all lipid molecules, and means that when suitably organised 
they are capable of serving as a boundary between aqueous regions. Two of the most 
commonly studied lipids in membranes are the phosphatidyl cholines, members of the class of 
phospholipids, and the sterol cholesterol. The high hydrocarbon content of these molecules is 
immediately apparent: one would not expect them to be soluble in water. When we examine 
the structure of phosphatidyl choline more closely, we can distinguish two main features. 
Firstly the long hydro-carbon chains, in addition, a polar group, the phosphate ester of 
choline, which is attached to C-3 of the glycerol. We would expect this polar group to prefer 
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an aqueous environment. The forces involved in this interaction are clearly those of polar 
groups being stabilised in a polar environment, and also a strong hydrophobic interaction 
between the adjacent hydrocarbon chains of the phospholipids. In many ways the 
phospholipid molecules, in their orientation at an aqueous surface, are behaving like detergent 
molecules. Detergents are also amphipathic (contain both a polar and an apolar group) and 
can form micelles. Micelles are short lived aggregates of amphipathic molecules. 
 
One of the most characteristic properties of a liquid is its fluidity, and this is thought to 
be a very important property of biological membranes. Too rigid membranes may prevent the 
diffusion of small molecules across the bilayer or inhibit membrane-bound proteins. A cell 
with too fluid a membrane may be over-fragile and unable to maintain its internal 
environment satisfactorily. 
 
Membrane proteins in general -  
 
Membranes are selectively permeable barriers which compartmentalise, and thereby 
exert considerable control over, cellular metabolism. They provide the support and working 
environment for a great variety of enzymes, receptors and antigens, each of which interact 
with soluble material in the aqueous milieu either at one or both surfaces of the membrane. 
Sites may also be provided through which the membrane can interact with cytoskeletal 
elements, as in cell movement or during secretion. All of these functions are achieved by a 
hydrated structure that is essentially constructed of a bilayer of lipid molecules with which 
various types of proteins and glyco-proteins are associated: some penetrate through the lipid 
bilayer, some are inserted into it only from one side, whilst others are associated with the 
membrane in a more superficial manner which does not involve direct interaction with the 
inner parts of the lipid bilayer. Most membrane functions are the functions of the membrane 
proteins and glycoproteins, and the relative variety and abundance of the protein species 
found in any individual membrane are to some extent a reflection of the diversity and 
intensity of its biological activities.  
 
The proportion of the dried weight of various membrane preparations which is protein 
varies within the range of 20 to 75%. At the lower extreme is nerve myelin which exhibits 
only a few relatively weak enzyme activities: its major function appears to be as an electrical 
insulator. An example of the membrane which has about three-quarters of their dried weight 
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as protein is the inner mitochondrial membrane which has a highly complex mixture of 
components involved in electron transport, ATP synthesis, solute transport and membrane 
potential (proton motive force). The interpretation in structural terms of this variability in 
protein content between different membrane proteins is not straight forward, in that it must 
take account of the fact that some proteins are superficially attached at the hydrated surfaces 
of membranes (extrinsic or peripheral proteins) whilst others include regions which are 
inserted to a significant extent into the apolar interior of the membrane (intrinsic or integral 
proteins). 
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Uncoupling proteins –  
 
   Uncoupling proteins (UCPs) belong to the mitochondrial anion carrier family. These 
proteins mediate a regulated discharge of the proton gradient that is generated by the 
respiratory chain. UCP2 was discovered in 1997, revealed by screening the human and mouse 
expressed sequence tag (EST) libraries (Fleury et al.1997; Gimeno et al.1997). Its mRNA has 
been identified in several tissues as heart, kidney, lung, placenta, white fat and tissues of the 
immune system. Human UCP2 shows 59% homology with the well-known UCP1 of brown 
adipose tissue (BAT) mitochondria, also called thermogenin (Fleury et al.1997; Gimeno et 
al.1997). It was found that UCP1 allows protons to re-enter into the mitochondrial matrix, 
uncoupling the electron transport from oxidative phosphorylation (synthesis of ATP). The 
result is heat production (Klingenberg 1990; Nicholls 1979). 
 
It is accepted that BAT and UCP1 are involved in the so-called non-shivering 
thermogenesis that is the phenomenon of absence of shivering in newborn, cold acclimated 
and hibernating mammals (Nedergaard and Cannon 1992). When new UCP isoforms (UCP2 
to UCP5) were identified in humans or in rodents, mitochondria were recognized not only as 
simple energy generators, but also as organelles regulating various physiological phenomena 
(Ježek et al.2004). 
 
The physiological functions of UCP2 are still unknown. It may play a role in muscle 
non-shivering thermogenesis, regulation of body weight and in protection against formation 
of reactive oxygen species (ROS) (Nedergaard and Cannon 2003). ROS are significantly 
produced in mitochondria (Turrens 1997; Brookes et al. 2004; Boveris and Change 1973; St. 
Pierre et al. 2002; Staniek et al. 2002; Kwong and Sohal 1998). Any slight increase of the H+ 
back flux to the matrix, which diminishes the proton motive force ∆p (electrochemical H+ 
gradient), has been shown to decrease ROS generation (Brookes et al. 2004); this is a well 
documented phenomenon from experiments using artificial uncouplers (Korshunov et al. 
1998; Skulachev 1998). The function of UCP2 as an uncoupling agent could therefore be to 
keep the membrane potential sufficiently low for ROS production to be minimized 
(Nedergaard and Cannon 2003). Consequently great pharmacological potential is expected in 
revealing biochemical and hormonal regulation of UCP2. Recent work has shown that the 
UCP homologues are activated by a superoxide dependent mechanism. This observation led 
to the suggestion of a feedback mechanism which controls the production of reactive oxygen 
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species; however, the importance of the UCP homologues in cellular antioxidant defense is 
not clear at this point. Although the physiological functions of UCP2 and UCP3 remain 
uncertain, it has been shown that UCP2, by virtue of its proton-leak activity, has an important 
role in the patho-physiology of type-2 diabetes. In particular, hyperglycaemia causes a 
pathological, superoxide dependent activation of UCP2 in pancreatic islets, which, in turn, 
causes loss of glucose-stimulated insulin secretion. 
 
Further work is required to elucidate the physiological roles and regulation of UCP2 
and UCP3, and to understand, at a molecular level, how they mediate proton leak. This will 
have implications for many pathologies and diseases: for example, targeted inhibition of 
UCP2 should be a useful tool in the treatment of pancreatic- -cell dysfunction and type-2 
diabetes. 
 
Structure and mechanism – 
 
UCPs have a characteristic molecular mass of 31-34 KDa and a tripartite structure in 
which a region of around 100 residues is repeated three times; each repeat codes for two 
transmembrane segments and a long hydrophilic loop. The three internal repeats are 
homologous to each other and form six membrane-spanning quasi α-helices (Fig.1.1). 
 
In UCPs the C- and N-ends are located on the cytosolic side of the mitochondrial inner 
membrane, resulting in four cytosolic and three matrix segments ( Klingenberg 1990; Moualij 
et al. 1997). Because of similar structure to UCP1, there is substantial evidence to assume an 
identical molecular mechanism of uncoupling for UCP2, even if the question is still 
controversial.   
 
UCP1 catalyses the flip-flop transport of the anionic fatty acid (FA) head group from 
one side of the membrane to the other (Fig.1.2) (Garlid et al. 1996). It enables FA to behave 
as cycling protonophores, dissipating H+ gradient and preventing ATP synthesis on F0F1-
ATPase (Ježek and Garlid 1998). 
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Intermembrane space 
 
Matrix 
Fig. 1.1: Mammalian (rat) uncoupling protein structure – a model for trans-membrane 
spanning as suggested by Klingenberg. The shadowed areas are the loci interacting with purine 
nucleotide di- and triphosphates. 
 
 
Normally, despite high electrical gradient in vivo, there is no significant flux of FA 
anion because the bilayer energy barrier is high. The mechanism of uncoupling for UCP1 has 
been demonstrated to be the following: the FA anion from the matrix bilayer leaflet diffuses 
laterally to reach the protein and interacts with the internal binding site that lowers the energy 
barrier; the electric field drives the anionic head group to the energy well. The hydrophobic 
tail moves to the other side of the membrane principally by the same mechanism that occurs 
as the flip-flop of the protonated fatty acid; protonation is now insured by the protein. After 
the release from the internal binding site, protonation of the FA at the opposite site of the 
membrane proceeds and neutral FA can rapidly flip-flop back (Garlid et al.1996).    
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Fig. 1.2: Fatty acid cycling 
 
 
The net transport of protons is regulated in several ways. Adenine nucleotides strongly 
inhibit transport, whereas FAs serve as activators. The regulatory purine nucleotide (PN) 
binding site is purely allosteric (Ježek and Garlid 1998).The receptor site has a high affinity to 
PN di- and triphosphates and a low affinity to PN monophosphates; pyrimidine nucleotides 
neither bind to UCP1 nor inhibit transport (Klingenberg et al.1990; Winkler et al.1997). 
Purine nucleotide binding and inhibition decrease with increasing pH. The inhibited 
conformation is achieved only when the α-phosphate binds to R276. This induces 
conformational changes occluding the internal fatty acid binding site, causing inhibition of 
transport (Garlid et al. 1996; Modriansky et al. 1997). 
 
The transport pathway is predicted to possess an internal weak binding site near the 
middle point of the membrane and to lie on an outside surface of one of the transmembrane 
helices at the protein-lipid interface. It is usually assumed that UCP2 have identical molecular 
properties as UCP1. Fatty acids were found to be essential also for UCP2 induced uncoupling 
and ATP and GDP to be inhibitors of the supposed mechanism. EPR spectroscopy of spin-
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labelled fatty acids was used to investigate the putative FA binding site on UCP2 and the 
existence of a distinct nucleotide-binding site. 
 
The alignment of the amino acid sequences of UCP1, UCP2 and UCP3 shows that 
these proteins are significantly similar (Fig 1.3 and Table 1.1). These proteins exhibit a 
triplicated structure and a signature motif that is also present in other mitochondrial carriers. 
A similar organization was observed in plant UCPs. No N-terminal mitochondrial cleavable 
targeting sequence is present in UCP1, and sequence comparison suggests that the other UCPs 
are similar. Computerized analysis of the secondary structure of the UCPs predicted the 
existence of six transmembrane domains linked by polar loops (Aquila, H et al. 1985, 
Bouillaud, F et al. 1986). Several antigenic sites in rat UCP1 were identified in an approach to 
study the topology of protein in mitoplasts and sonicated mitoplasts. These studies validated 
the predicted secondary structure of UCP1. Considering the above studies and the present data 
explained in our study, it can be proposed that the different UCPs share the same type of 
folding in the membrane. 
 
EPR spectroscopy - 
 
Electron Paramagnetic Resonance (EPR), often called Electron Spin Resonance 
(ESR), is used for the branch of spectroscopy that studies paramagnetic molecules, that is 
molecules with unpaired electrons. Biologically important paramagnetic species include free 
radicals and many transition elements. In addition there is substantial and rapidly growing use 
of synthetic stable free radicals (eg: spin labels) to obtain information on a wide variety of 
complex biochemical systems such as macromolecules and membranes. 
 
Theory 
 
An isolated electron, all alone in space without any outside forces, has an intrinsic 
angular momentum (impulse) called spin. In general the spin s is limited to 2s+1 discrete 
states. For a single unpaired electron s= ½, so there are only two possible spin states, which 
we can consider as spin in opposite direction and that have the same energy in the absence of 
a magnetic field. The value that s takes along a specified direction (z axis) is then +1/2 or –
1/2. (The two spin states of the electron are often labelled by their values of ms). Because of 
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its charge and angular momentum the electron generates a magnetic field, so it acts like a little 
bar magnet or magnetic dipole with a magnetic moment µ (Fig.1.3).  
   
 
 
Fig. 1.3: Free, unpaired electron in space: electron spin, magnetic moment 
 
 
Zeeman effect 
 
If the unpaired electron is placed in an external magnetic field B0, its magnetic 
moment interacts with the magnetic field, producing two energy levels, otherwise 
degenerated. This effect is called Zeeman effect. The energy of interaction is equal to the 
product of the magnetic field and the projection of the magnetic moment µ along the direction 
of the magnetic field, which is generally defined to be z:   
 
E = µzB0 
 
However, unlike the magnetic moment of the bar magnet, the quantum nature of the 
electron restricts its magnetic moment to two possible orientations, parallel or antiparallel to 
the field.  Hence it will have a state of lowest energy when its moment is aligned with the 
magnetic field and a state of highest energy when the moment is aligned against the magnetic 
field (Fig.1.4). 
 
 
Fig. 1.4: Minimum and maximum energy orientations of µ with respect to the magnetic field 
B0. 
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The magnetic moment µz of an electron is proportional to its spin through the 
relationship:                                   
µz = geβms 
 
where β is a conversion constant called “Bohr magneton” and ge is the spectroscopic g 
factor of free electron called Landé factor and equals to 2.0023. Therefore the energy in the 
magnetic field is: 
E = geβB0ms 
 
Consequently in a magnetic field two energy levels exist:            
 
E = +1/2geβB0    and     
E = -1/2geβB0 
 
separated in energy by an amount geβB0 (Fig.1.5). From this equation derives that in 
absence of magnetic field there is only one energy level and that the energy difference 
depends linearly on the magnetic field. 
 
  
 
 
 
 
 
 
Fig. 1.5: Energy levels of an unpaired electron in a magnetic field. 
 
 
Electromagnetic radiation of frequency ν such that hν = geβB0 can be used to induce 
transitions between these levels (Fig.1.6). At the magnetic fields usually used for ESR 
experiments, the separation of the levels is such that this frequency lies in the microwave 
region of the electromagnetic spectrum. 
 
ms = - 1/2
B0 = 0 
ms = + 1/2 
∆E = hv = geβB0 
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Fig. 1.6: Variation of the spin state energies as a function of the applied magnetic field B0. 
 
 
Hyperfine splitting 
 
The basic ESR resonance line from the electron can be split in to two or more 
hyperfine lines, if the unpaired electron spends significant time close to nuclei with magnetic 
moments, so that there can be magnetic interaction between magnetic nuclei and the electron 
(Fig.1.7). Nuclei have magnetic moments if they have net nuclear spin (I≠0). The splitting of 
the energy levels of the unpaired electrons is due to the small magnetic field BI associated 
with nuclei that have magnetic moments. This magnetic field opposes or adds to the magnetic 
field from the laboratory depending on the alignment of the moment of the nucleus. When BI 
adds to the magnet field, we need less magnetic field from our laboratory magnet and 
therefore BI lowers the field of resonance. The opposite is true when BI opposes the 
laboratory field. 
 
In biological systems, nuclei with magnetic moments include nitrogen 14N (I=1), 
hydrogen 1H (I=1/2), deuterium 2H (I=1), and carbon 13C (I=1/2), as well as nuclei of some 
transition metals. Magnetic moments of nuclei are only about 1/600 as large as that of the 
electron and may have several possible values instead of only two. The number of possible 
values of magnetic moments is 2I+1, where I is the spin of the nucleus. So the magnetic 
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interaction between magnetic nuclei and the electron produces a splitting of the basic 
resonance line into 2I+1 number of hyperfine components. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.7: Simple modifications of ESR lines (hyperfine splitting) due to interaction of the 
unpaired electron with particular nuclei.  a) Interaction with a proton I =1/2; possible spin states mI = 
+1/2; -1/2.  b) Interaction with nitrogen I = 1; mI = 1, 0, -1. 
 
 
The effect of hyperfine interaction is to add a term to the energy expression for an 
EPR transition: 
∆E = hν= geβB0  + hAmI 
 
where A is called the hyperfine coupling constant (measured in cm-1 or MHz) and mI 
is one of the 2I+1 projections of the nuclear spin. 
 
Hyperfine splittings are dependent on the orientation of the molecules in the magnetic 
field; in particular their magnitude depends on the angle between the axis of the molecule and 
the applied magnetic field. When the molecule rotates sufficiently rapidly, anisotropic 
components are averaged out, but when the motion is slower, hyperfine lines begin to broaden 
(Fig.1.8). This rotation depends both on the size of the molecule and on the viscosity of the 
solution. 
B
∆E = hv = gβB0 
B0 
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Fig.1.8:Normalized EPR spectra of a spin label with increasing viscosity/motional restriction. 
 
 
The g-factor 
 
In analogy with orbital angular momentum, for which the magnetic angular moment 
along z axis is µL=βmL, the magnetic moment of the electron µz should be βms. However, 
detailed interpretation of early experimental results showed that the actual magnetic moment 
appeared to be twice this. More recent experiments have shown that it is more correct to 
write:         
µz = geβms 
 
where ge is the g-value of the free electron (2.0023). 
 
The g-factor is defined mathematically as g = hν/βB. For symmetrical ESR spectra, 
the g-value can be obtained from the field position of the centre of the resonance. For most 
free radicals the g-value is close to the value for the free electron. However, small deviations 
from the free electron value that are found are quite significant. In particular, shifts occur for 
unpaired electrons located near nuclei with low-lying excited states (e.g. oxygen, sulphur and 
especially transition elements); coupling of the spin of the electron to the orbital motion can 
occur, and as a result, the g-value shifts. Such shifts can greatly assist in the identification of 
unpaired electron species in complex biological systems.  
 
freely tumbling
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Just as the hyperfine interaction, the g-value of a paramagnetic molecule oriented in 
space depends upon the direction along which it is measured; it is anisotropic. Again, when 
the molecules undergo very rapid rotation, the isotropic components of the g-value average 
out, but with slower motion these components affect the spectrum (Fig.1.8). 
 
Spin labels 
 
 A spin label is a paramagnetic group, usually a nitroxide stable free radical that is 
introduced to make the experimental system accessible to be studied by ESR. Spin labels can 
provide information on motion, both the motion of the spin label itself and of the molecule or 
molecular system to which it is bound, and also provide information on the chemical nature of 
the environment of the site at which the label is bound.  
 
The major structural elements of a nitroxide spin label are the nitrogen-oxygen bond, 
which contains the unpaired electron, necessary to produce an ESR signal, and the steric 
hindrance of the NO group by bulky groups on the carbon atoms attached to the nitrogen. In 
the usual convention, the z axis extends along the nitrogen’s p orbital, in which occurs much 
of the spin density, the x direction is along the N-O bond, and y is mutually perpendicular to x 
and z (Fig 1.9). 
 
 
 
 
 
 
Fig. 1.9: Chemical structure of a nitroxide spin label. 
 
 
The ESR spectrum of a nitroxide spin label is split into three principal lines because of 
interactions with the nitrogen nucleus (which has spin of 1). The magnitude of this hyperfine 
splitting depends on the orientation of the nitroxide free radical in relationship to the applied 
magnetic field. It is this fact combined with the orientation dependency of the g-values that 
makes nitroxide spin labels so useful in biochemistry. The ESR spectrum of a nitroxide spin 
label depends in a complex manner on both the rate and the symmetry of rotation of the 
nitroxide group.  
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The rate of tumbling for a molecule undergoing Brownian motion can be expressed in 
terms of a correlation time τ (Griffith and Waggoner 1969). A naïve definition of τ is simply 
the average time required for a nitroxide to rotate through a significant arc (say 40°). τ is 
inversely related to the tumbling rate of the molecule and it should be in the range between 
10-7 and 10-11 sec. At rotation greater than 10-11 sec, the asymmetrical features in the spectra 
are averaged out completely, resulting in a narrow three line spectrum. At rotation rates 
slower than 10–7 sec, the spectrum closely resembles that of a completely immobilized free 
radical. The aim of many calculations is to relate the ESR line shapes to the parameter τ. 
 
The most useful approaches to study anisotropic motions are available for the 
particular situation where the spin label is associated with a molecular system in which there 
is a rotation about one long axis and one short axis (axial symmetry) (Swartz and Swartz). 
This motion is typical of, for example, a spin-labelled lipid in a membrane. Thus, 
asymmetrical rotation such as one might expect in a long, narrow molecule produces 
characteristic changes in the ESR spectrum that indicate that this molecule is rotating about its 
long axis in preference to tumbling about one of its short axes. ESR spectra change from the 
situation where the only possible motion is rotation along the long axis of the fatty acid spin 
label (order parameter S=1) to the entirely random orientation (S=0). For example, if the 
viscosity of the solution is increased, the rotational motion of the nitroxides decreases and the 
spectra become increasingly asymmetric. 
 
To study our protein system, we used spin-labelled fatty acids and, in particular, 7-
DOXYL stearic acid (DOXYL=4,4-dimethyloxazolidine-N-oxyl) and 4-PROXYL palmitic 
acid (PROXYL=2,2,5,5-tetramethylpyrrolidin-N-oxyl). The first one is commercially 
available from the company TCI Europe Ltd, Belgium, the second was a kind gift from Prof. 
Hideg, Hungary.    
                        
a)                         
 
 
 
 
 
O
N  
OH(CH2)9CH3
O
CH3
H3C
O
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b) 
 
 
 
 
 
 
 
Fig.1.10: a) Structure of 7-DOXYL stearic acid; b) Structure of 4-PROXYL palmitic acid. 
 
 
The instrument 
 
ESR spectra were measured on a Bruker Elexsys E580 spectrometer, operating in the 
X-band mode (9.7 GHz). Essential components of a simple ESR spectrometer are a 
microwave source (a klystron or, nowadays, a Gunn diode), a magnet and a detector 
(Fig.1.11). The electromagnetic source and the detector are in a box called “microwave 
bridge”; the sample is held in a quartz capillary tube, with an internal diameter of 1mm or 
0.6mm, and placed in a microwave cavity, which is a metal box that helps to amplify weak 
signals from the sample (Berliner 1976, 1979). 
 
The Bruker EPR spectrometer used is a reflection spectrometer: it measures the 
changes - due to spectroscopic transitions - in the amount of radiation reflected back from the 
microwave cavity containing the sample. The detector has to see only the microwave 
radiation coming back from the cavity. A Schottky barrier diode is used to detect the reflected 
microwaves: it converts the microwave power to an electrical current. 
 
During the experiment the frequency of radiation is fixed and the magnetic field is 
scanned. The required magnetic field for the study of free radicals at ~9 GHz is about 3200 
Gauss and it is readily achieved with conventional electromagnets. As the resonance condition 
is approached the sample absorbs microwave energy and we see the peak in the spectrum. 
 
 
 
 
N
N  
OH
O
(CH2)8
CH3
CH3H3C
O
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Fig. 1.11: Block diagram of a simple ESR spectrometer. 
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OBJECTIVE   
 
The uncoupling proteins (UCPs) are transporters, present in the mitochondrial inner 
membrane, that mediate a regulated discharge of the proton gradient that is generated by the 
respiratory chain. This energy-dissipatory mechanism can serve functions such as 
thermogenesis, maintenance of the redox balance, or reduction in the production of reactive 
oxygen species. Some UCP homologs may not act as true uncouplers, however, and their 
activity has yet to be defined. Uncoupling proteins are a unique group of closely related 
proteins that may play important roles in obesity, diabetes, fatty acid metabolism, and 
neurodegeneration. The UCPs are integral membrane proteins, each with a molecular mass of 
31-34 kDa and a tripartite structure in which a region of around 100 residues is repeated three 
times; each repeat codes for two transmembrane segments and a long hydrophilic loop. The 
functional carrier unit is a homodimer. So far, 45 genes encoding members of the UCP family 
have been described, and they can be grouped into six families. Most of the described genes 
are from mammals, but UCP genes have also been found in fish, birds and plants, and there is 
also functional evidence to suggest their presence in fungi and protozoa. UCPs are encoded in 
their mature form by nuclear genes and, unlike many nuclear-encoded mitochondrial proteins, 
they lack a cleavable mitochondrial import signal. The information for mitochondrial 
targeting resides in the first loop that protrudes into the mitochondrial matrix; the second 
matrix loop is essential for insertion of the protein into the inner mitochondrial membrane. 
The UCP proteins are composed of six membrane spanning alpha helices, and both the C and 
N terminus protrude from the cytosolic side of the mitochondrial inner membrane. This is 
only a secondary structure prediction as the structure of the protein is not yet known. UCPs 
are regulated at both the transcriptional level and by activation and inhibition in the 
mitochondrion. 
 
Uncoupling protein 1 was discovered from functional studies of brown adipose tissue 
mitochondria and was one of the earliest membrane proteins to be sequenced. Several 
important observations lead to the discovery of UCP1. This protein was originally named 
“thermogenin” but now is more commonly known as uncoupling protein 1. UCP1 was 
originally thought to be a unique protein found only in mammalian brown adipose tissue, but 
further research has revealed at least five uncoupling proteins. UCP1 is considered the classic 
uncoupling protein, and considerable research has linked UCP1 with cold induced 
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thermogenesis and is found exclusively in brown adipose tissue. Mammals have five UCP 
homologs, of which UCP1-UCP3 are closely related, while UCP4 also known as brain 
mitochondrial carrier protein (BMCP1) expressed only in the brain, physiological function 
largely unknown, is more divergent. UCP2 was discovered in 1997 and shares 58% sequence 
homology with UCP1 and 80% with UCP3.   
 
Unlike UCP1, UCP2 is expressed ubiquitously in mammalian tissues and is believed 
to be a peripheral target for energy dissipation and may have roles in body weight regulation. 
However, there has been considerable debate about the functions associated with UCP2. 
Recent evidence from Jaburek et al. seems to support their role as uncouplers because ion 
fluxes of purified UCP2 and UCP3 were identical to UCP1 suggesting that these are 
functioning uncoupling proteins with a physiological role in energy dissipation. However, 
establishing physiological roles for UCP2 and UCP3 may be dependent upon improved 
experimental technique, as current methods have proven insufficient to answer questions 
regarding the structure and functional relationship of these novel proteins. Many studies of 
UCP1 relied on expression of the protein in yeast, however, because UCP2 and UCP3 only 
occur in low concentrations they must be over-expressed in yeast or E. coli. Although this 
technique proved highly successful with UCP1 it does not appear to work with UCP2 or 
UCP3 because they are not in native conformations when expressed in E. coli or yeast. 
 
The function mediated by classic uncoupling protein1 in energy dissipation was 
explained by Ježek et al. Considering the studies of Jaburek et al. as elementary, we started to 
study the function of UCP2. During this course we have studied the foray of reactions 
catalysed by UCP2 and at the same time also deduced a reliable experimental technique for 
the over-expression of UCP2 and to isolate it in native conformations. Virtually nothing is 
known about the transport functions of UCP2 and UCP3, and their putative physiological 
functions have been deduced primarily from their striking sequence homology with UCP1. 
Addressing this problem was one of the major tasks, which is discussed in this present work. 
The protein was expressed in E.coli and aggregated into inclusion bodies, by which method 
we achieved sufficient amounts of protein for our experiments. The main objective of our 
work was to explain how the energy dissipation and heat generation is catalyzed by back-flux 
of protons into the mitochondrial matrix, probably by fatty acid cycling mechanism. We have 
reconstituted the protein into detergent liposomes and measured the fatty acid cycling 
mechanism with a myriad of substrates and competitors. In addition to this we also planned to 
Objective 
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deduce whether fatty acid dependent proton transport by UCP2 was inhibited by purine 
nucleotides, albeit with lower apparent affinities than observed with UCP1 by Ježek et al, in 
order to evaluate that UCP2 is a functional uncoupling protein and that its biophysical 
properties are consistent with a physiological role in energy dissipation. 
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ABBREVIATIONS 
 
AA  Arachidonic acid 
ADP  Adenosinediphosphate 
ATP  Adenosinetriphosphate 
BAT  Brown adipose tissue 
BMCP  Brown mitochondrial carrier protein 
BSA  Bovine serum albumin 
C12E9   Nonaethylene glycol monododecyl ether 
db  decibel 
DSA  DOXYL stearic acid 
DTT  Dithiothreitol 
DOXYL 4,4-dimethyloxazolidine-N-oxyl 
EST  Expressed sequence tags 
EDTA  Ethylenedinitrilotetraaceticacid 
EPR/ESR Electron paramagnetic/spin resonance 
ETA  Eicosatrienoic acid 
FA  Fatty acid 
G  Gauss 
GDP  Guaninediphosphate 
GHz  Giga hertz 
HLA  12-hydroxy lauric acid 
HNE  4-hydroxy nonenal 
IB  Inclusion bodies 
IPTG  Isopropyl-ß,D-thiogalactopyranoside 
K  Kelvin 
kDa  kilo dalton 
NO group nitric oxide group 
OA  Oleic acid 
ODS  Octadecane sulfonate 
PA  Palmitic acid 
PA buffer Phospho Acetate buffer 
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PMSF  Phenylmethylsulfonylflouride 
PN  Purine nucleotides 
PPA  PROXYL palmitic acid 
PROXYL 2,2,5,5-tetramethylpyrrolidin-N-oxyl 
ROS  Reactive oxygen species 
SDS  Sodium dodecyl sulphate 
SL  Spin label 
SLFA  Spin-labelled fatty acid 
SLS  Sodium N-lauroylsarcosine  
TCA  Tri chloroacetic acid 
TE buffer TRIS-EDTA buffer 
TRIS  Tris (hydroxymethyl) aminomethane 
UCP  Uncoupling protein 
UDS  Undecane sulfonate 
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METHODS 
 
Expression of uncoupling protein in E.coli –  
 
 Human uncoupling protein 2 (UCP2) open reading frames were amplified by PCR and 
inserted into the NdeI and NotI sites of the pET21a vector (Novagen). By DNA sequencing, 
the construct is predicted to encode protein with an amino acid sequence identical to the wild 
type UCP2 protein. Plasmids were transformed into bacterial strain BL21 (Novagen). The 
cloning of UCP2 plasmid was done by Martin Jaburek (protocol published), the protein 
expression and below mentioned inclusion bodies isolation was performed in Prague at the 
department of Dr.Ježek. The transformed cells were used for bacterial expression of 
uncoupling protein and its isolation in inclusion bodies. 
 
Solutions and Media: 
 
2 x YT medium:  Bacto-tryptone 8gm 
   Bacto-yeast extract 5gm 
   sodium chloride 2.5gm 
   distilled H2O  500ml (dissolve first in 450ml) 
 
 Shake until the solutes have dissolved and adjust the pH to 7.0 with 1N sodium 
hydroxide (NaOH). Make up the final volume to 500ml with distilled H2O. Sterilize the 
medium by autoclaving for 20 minutes at 120mb atm pr. 
 
PA buffer:   phosphate (Na+ salts) 150mM 
   EDTA   25mM 
   ethylene glycol 5% (w/v) 
   pH – 7.9 
 add 1mM DTT and 2mM PMSF just prior to use. 
 
Carbenicillin:  Na salt, use 100µg/ml final concentration 
 
IPTG:   0.5M stock solution.  
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   Dissolve 1.2gm of IPTG (isopropyl–β-D-thiogalactopyranoside) in 10 
ml of distilled H2O and filter sterilize the solution by passing through a 0.22 micron 
disposable filter. 1ml aliquots are stored at -20°C. 
 
TE buffer:  TRIS   100mM 
   EDTA   1mM 
   pH – 7.8 (adjust by 1N HCl) 
 add 1mM DTT and 2mM PMSF just prior to use. 
 
Procedure: 
 
1) Prepare 0.5 lit of 2 x YT medium, and add carbenicillin at a final concentration of 
100µg/ml. 
2) Always start from the frozen stock –  
Scrape a few microliters from the surface with inoculation loop, return the culture to   
-80°C freezer without thawing. 
Plate this E.coli on 2 x YT plates containing carbenicillin. Incubate overnight at 37°C. 
3) Grow small culture from single bacterial colony in 3ml of 2 X YT medium containing 
carbenicillin. Incubate at 20°C over night. 
4) Inoculate the 0.5 lit of 2 x YT medium with 2ml of overnight culture from above step, 
incubate the medium at 37°C with aeration, until A600 reaches 0.3 – 0.4. 
5) Induce the expression in the medium by adding IPTG to a final concentration of 1mM. 
Continue incubation at 30°C with aeration for 3 – 4 hours. 
 
 
All following steps are carried out at 4°C – 
 
6) Harvest the cells using a GSA rotor. Centrifuge 2 x 250 ml of the cell culture at 500 x 
g for 15 min. (store at -20°C.) 
7) Suspend the cell pellet in 20 ml of ice-cold TE buffer and pass it twice through a pre- 
cooled French pressure cell. The resulting lysate is centrifuged 2 x 10 ml at 27,000 x g 
for 15 min ( or 20,000 x g for 25 min), using a SS34 rotor. 
8) The pellet is homogenized in TE medium, centrifuge at 1,000 x g for 3 min. Regain 
the supernatant from this step. 
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9) Centrifuge the supernatant from above step at 14,000 x g for 15 min. 
10) Weigh the resulting final pellet (inclusion bodies): 
11) Resuspend the pellet with PA buffer and centrifuge 1 ml aliquots of the resulting 
suspension at 14,000 x g for 15 min in a microcentrifuge. 
 
Volume of PA buffer used for resuspension: 
 
12) Store the pelleted inclusion bodies from above centrifuge step frozen at -70°C. 
[Note: The inclusion bodies become less soluble upon aging in freezer.] 
 
 
Solubilization and refolding of uncoupling protein from inclusion bodies –  
 
 To refold bacterially expressed uncoupling protein by functional reconstitution to its 
native conformation for binding studies. 
 
Solutions and chemicals: 
 
PA buffer:  phosphate (Na+ salts) 150mM 
   EDTA   25mM 
   ethylene glycol 5% (w/v) 
   pH – 7.9 
   add 10mM DTT and 2mM PMSF just prior to use. 
 
TE buffer:  TRIS   100mM 
   EDTA   1mM 
   glycerol  10% (w/v) 
   pH – 7.8 (adjust by 1N Hcl) 
 
Solubilization buffer: 2% (w/v) SLS dissolved in TE buffer. 
   Add 1mM DTT and 0.2mM PMSF just prior to use. 
 
Dialysis buffer: Internal medium for a given experiment. 
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Procedure: 
 
All steps are performed at 4°C unless stated otherwise – 
 
1) Wash inclusion bodies to remove loosely bound protein contaminants: resuspend each 
inclusion bodies eppendorf in 1 ml of PA buffer and 2% Triton X 100. 
Centrifuge at 14,000 x g for 10 min in a microcentrifuge. Discard  supernatant 
carefully. 
2) Repeat the wash step. Add 1 ml PA buffer and 0.2% solubilization buffer to the pellet. 
Resuspend it and centrifuge at 14,000 x g for 10 min. 
3) Solubilize inclusion bodies: Add 1 ml of solubilization buffer to the resulting pellet 
from above step. Vortex well and use gentle pipetting to resuspend inclusion bodies to 
homogeneity. 
The above resuspended solution is incubated at room temperature for 15 min with 
occasional vortexing and gentle pipetting. 
4) Dilute this solution with TE buffer 4 fold (final volume 4 ml) and vortex. Centrifuge 
the suspension at 14,000 x g for 10 min to remove unsolubilized particles. 
5) Allow the supernatant to stand at 4°C, and simultaneously prepare refolding buffer. 
6) Prepare 6 ml of TE buffer with 0.1% C12E9 containing 1mM DTT and 0.1mM ATP 
final concentration, vortexed and mixed to homogeneity. (This is refolding buffer.) 
7) Dilute the supernatant from step 5 with the refolding buffer sequentially by adding 
500µl aliquots, every 30 min interval between each additions. 
 
[Final volume of resulting solution 10 ml] 
 
8) Dialyze the sample against TE buffer containing 0.1mM DTT, 0.1mM ATP, 1 gm 
BSA and 0.1% C12E9 for overnight at 1:100 dilution (1 lit). 
9) Now dialyze the sample with a fresh dialysis buffer for 8 – 9 hours. 
10) Final dialysis is performed against only TE buffer containing 0.1 % C12E9 for 
overnight. 
11) Concentrate the sample to ~1 – 2 ml, using the ultrafree–15 centrifugal filter device 
(Millipore). 
12) Centrifuge the resulting concentrate at 14,000 x g for 10 min to remove any 
precipitate. 
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13) Store the protein at -20°C or proceed to following step. 
14) The amount of protein is estimated by Lowry’s and BCA methods. 
 
Measure the volume of sample: 
 
15) The estimated protein is then concentrated to desired quantities using centricon or 
vivaspin-6 centrifugal devices. 
 
 
 
 
 
Reconstitution of bacterially expressed uncoupling protein into proteoliposomes. 
 
The functional reconstitution and solubilization of uncoupling protein is carried out by the 
same method as described above along with few additional solutions and steps as described 
below. 
 
Solutions and chemicals: 
 
Phospholipids: E.coli phospholipids (100mg/ml in chloroform) dried under nitrogen, 
stored under vacuum. (use ~10mg/mg protein) 
 
All other buffers required are same as described in previous method. 
 
Procedure: 
 
The following steps are carried on after the concentration of protein followed by dialysis as 
discussed above. 
 
[Note: Phospholipids (~10mg/mg protein) are added in the refolding buffer, vortexed and 
sonicated to homogeneity.] 
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Hydroxyapatite treatment – 
 
1) For each ~2mg of protein aliquot, prepare 0.4mg of hydroxyapatite (HTP) in a 
column.  
2) Wash the column by letting at least 10ml of the dialysis buffer pass through and spin 
500 x g for 1 min to remove residual medium. 
3) Now load the sealed HTP column with the protein solution and let sample pass 
through gravity. 
4) Spin the column at 500 x g for 1 min to collect the remaining sample. 
 
Bio beads treatment –  
 
Prepare 2 x 2.5 ml of pre-washed bio beads (in distilled water or ethanol) columns: 
 
a. Seal two 5cc syringes with fibreglass. 
b. Remove water or ethanol from bio beads by centrifugation at 800 x g for 1-2 mins. 
c. Wash the bio beads in syringes with dialysis buffer using a volume 4 to 5 times the 
packed volume. 
d. Seal the syringe outlet, apply more dialysis buffer and let equilibrate over night. 
 
1) Remove 0.5 ml of the pre-equilibrated bio beads to a separate syringe sealed with fibre 
glass. 
2) Spin the syringe at 800 x g for 2 min to remove residual medium and seal the outlet. 
3) Add the protein sample to the syringe and incubate the mixture at 4°C for 30 min. 
4) At every consecutive 30 min interval keep adding the bio beads to the syringe by 
preparing as in step 1. 
5) Repeat the steps until the final volume of bio beads is 2 ml. 
6) Separate the proteoliposomes from bio beads by centrifuging at 800 x g for 2 mins. 
7) Add the proteoliposomes to a fresh prepared bio beads column as described in step 1 
and incubate for additional 30 – 60 mins. 
8) Now centrifuge column at 800 x g for 2 mins. 
9) Measure the volume of resultant proteoliposomes. 
 
V =  
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10) Estimate the protein concentration in the proteoliposomes. 
 
P = 
 
 
 
Amido Black protein estimation –  
 
The procedure is used to determine microgram quantities of protein in the presence of 
milligram levels of lipids. 
 
Solutions and chemicals: 
 
10% (w/v) SDS 
100% (w/v) TCA  
6% (w/v) TCA 
1 M TRIS in 1% (w/v) SDS medium, pH 7.5 
Staining solution: 0.1% (w/v) Amido Black 10B dissolved in methanol/acetic acid/ 
distilled water (v/v/v 90/2/8) 
Destaining solution: methanol/acetic acid/ water (v/v/v 90/2/8) 
25mM NaOH/0.05mM EDTA/ 50% (v/v) ethanol. 
Calibrated 0.2 mg/ml BSA. 
 
Materials: 
 
Millipore filters (0.45µm pore size) 
Millipore filtration system connected with vacuum 
 
Procedure: 
Preparation of Millipore filters –  
 
1) Number each filter at the edge, taking care of the surface of the filter. 
2) Soak the filters in distilled water until use. 
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3) Place filters with labelled side facing bottom on the filtration system. 
4) Place flange over filters, careful not to rip filters. 
5) Remove water just prior to use. 
 
Prepare standards and samples for estimation –  
 
1) Dilute the protein samples and standards to final volume of 2 ml with distilleded water 
in separate tubes. 
2) Add each sequentially to the samples, letting follow thorough vortexing of mixture- 
a. 0.2 ml 10% SDS 
b. 0.3 ml 1 M TRIS in 1% (w/v) SDS medium, pH 7.5 
c. 0.6 ml 100% (w/v) TCA 
3) Incubate the samples for 3 – 4 mins. 
4) Transfer the samples to above numbered filters and dry filter under vacuum. 
5) Wash filters with 2 ml of 6% (w/v) TCA, vacuum-dry thoroughly. 
6) Remove filters and soak in 200 ml of staining solution for 3 mins. 
7) Rinse filters quickly with 200 ml distilled water 
8) Wash filters in 200 ml destaining solution for 3 times with 1 min each wash. 
9) Again rinse filters in 200 ml distilled water for 2 mins. 
10) Place filters on wipes with stained side up and soak residual water. 
11) Add 0.7 ml of 25mM NaOH/0.05mM EDTA/ 50% (v/v) ethanol to each filter and 
incubate for 20 mins with occasional vortexing. 
12) Collect solution in microcuvettes and measure absorbancies at 630 nm wavelength. 
 
Tablesheet for an amido black protein assay: 
 
Sample Sample 
Amount 
Sample 
Conc (µg) 
Distilled 
water 
10% SDS 1M TRIS/ 
1% SDS 
100%TCA 
Standard 
Standard 
Standard 
Standard 
Sample 
Sample  
-- 
10 
50 
100 
25 
50 
-- 
2 
10 
20 
? 
? 
2000 
1990 
1950 
1900 
1975 
1950 
200 
 
300 600 
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Number of samples can be duplicated for better estimates. 
[Note: Volume in microlitres (µl)] 
 
 
Protein determination –  
 
Total protein determination was used for the inclusion bodies preparation as well as 
also for the reconstituted protein. While BCA test (BIORAD kit) was used for the amount 
of protein in inclusion bodies, the total protein after reconstitution was estimated using 
Lowry’s method. 
 
Using the BCA method the amount of protein in each aliquot of inclusion bodies 
freezed was standardized to ~2mg per eppendorf. 
 
 
EPR measurements –  
 
 EPR spectra were measured on a Bruker Elexsys E580 EPR spectrometer, operating in 
X-band mode (9.7 GHz). A dielectric cavity was used as the microwave source for 
experiments. Typically, 60µl or 30µl aliquots of solubilized UCP2 in C12E9 micelles were 
incubated with 4-fold excess of spin-labelled fatty acid. EPR spectra of the samples at 293K 
were obtained by averaging of atleast 2 to 3 scans with a scan width of 100 gauss at a centre 
field of 3452 G. The microwave power was set to 8mW, receiver gain of 64db to 72db with 
modulation amplitude of 1G. Intensities were adjusted by auto baseline correction.  
 
The parameters described above were established after a set of reasonable tuning 
conditions for the clear representation of bound regions in the spectra, the small scan width 
region spectrums of the bound regions only shown in some figures as overlay were recorded 
with better signal to noise ratio settings for better visibility. 
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MATERIALS 
 
Avanti Polarlipids:  Lecithin (soya bean) 
Becton Dickinson (BD): Bacto tryptone 
    Bacto yeast extract 
Biorad:   Amido Black 10B 
    BCA kit  
    Bio beads SM2 absorbent 
Gerbu:    Carbenicillin 
    Dithiothreitol  
    IPTG 
J T Baker:   Hydrochloric acid 
Millipore:   0.22 micron filters 
    Filtration system with vacuum 
Merck:    NaOH 
    NaH2PO4  
    EDTA 
    Ethylene glycol 
    Glycerol 
    Folin ciocalteus phenol reagent 
Omni fix:   1 ml syringes 
    0.45 micron filters 
Roche:    ATP 
    SDS 
ROTH:   Sodium chloride 
Sarstedt:   0.22 micron filters (for sterilization) 
Sigma:    BSA (Fraction V) 
    CTC 
    TRIS 
    PMSF 
    SLS 
    C12E9 
    Triton X-100 
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    Phospholipids 
    HTP 
    Dowex 11A8 Retardion 
    TCA 
Serva:    DOC 
 
Ethanol, methanol and acetic acid are of analytical grade from department chemicals facility. 
Microfuge centrifuge – Eppendorf 
Centrifuge – Beckman J2-21 model, Rotors used JA20. 
Spectrophotometer – Beckman DU640. 
Frenchpress – Sim Aminco SLM Instruments Inc. 
Vector – pET21a (Novagen) 
Competent cells – BL21 DE3 (Novagen) 
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RESULTS and DISCUSSIONS 
 
EPR spectroscopy is a significant biophysical technique that specifically detects 
unpaired electrons. Because the natural occurrence of such paramagnetic species in biological 
systems is relatively low, ESR sensitive reporter groups (spin labels or spin probes) can be 
introduced chemically into biological systems, either through chemical modification of the 
bio-molecule or via spin-labelled substrates or cofactors. The method is highly sensitive to 
conformational transitions within the vicinity of these reporter groups and therefore allows the 
evaluation of conformational/structural processes during substrate binding and often during 
enzymatic turnover. ESR is of great significance for studies of membrane proteins where 
many other biophysical methods are “relatively handicapped” due to the specific 
characteristics of membrane biology, e.g., ESR is unaffected by light scattering, and it can 
also be used at high viscosities of the samples. Furthermore, the relatively small size of the 
spin label usually does not significantly perturb the biological activity of the enzyme or 
protein. Requirements, however, are large amounts of protein and rather high protein 
concentrations (usually > 15µM) that are needed for acceptable signal/noise ratio of the 
resulting ESR spectra. Especially for membrane proteins this could be difficult to obtain, but 
for NMR studies it is even a tough task filling step where the concentrations requirement is 
1000 fold more due to the magnetic moments of electrons being higher than that of protons. 
 
The development of the solubilization/reconstitution from inclusion bodies allowed us 
to achieve adequate yields and functionally refolded protein for ESR spectroscopy, therefore 
allowing the use of this powerful biophysical technique to study this enzyme. In the present 
study hUCP2 has been isolated from inclusion bodies by solubilizing it in the non ionic 
detergent nonaethylene glycol monododecyl ether (C12E9), as mentioned in detail in previous 
chapters, to support our hypothesis which has been postulated by Garlid and Ježek long back 
that  uncoupling protein (UCP) probably mediates fatty acid cycling across the membrane by 
transporting anionic fatty acids which then flip-flop back via the lipid bilayer in a protonated 
form. In order to show that the substrate for UCP is fatty acids, we successfully used spin-
labelled fatty acids (SLFA) to study binding in soluble proteins. DOXYL stearic acid and 
PROXYL palmitic acid (kind gift from Prof.Hideg) were found to be our most useful probes 
for demonstrating the fatty acid cycling across the membrane. However we have to accept the 
truth that our method of solubilization or isolation of protein results in only 80% of active 
refolded protein and only partially mimics the in-vivo environment. The binding of spin-
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labelled fatty acid to the concentrated UCP clearly reveals the significance in our protein 
isolation method and on the other hand allowed us to study the competition with other 
substrates and ligands of UCP. In this study, we used spin-labelled fatty acids, contains a 
stable nitroxide radical attached at different positions along the chain of fatty acid. These spin 
probes have been successfully used in previous studies and demonstrated the binding with 
UCP [Ježek et al 1995]. We have been able to record EPR spectra of 4-PROXYL-palmitic 
acid (4-PPA) and 5-DOXYL-stearic acid (5-DSA) bound to UCP which clearly showed 
separated peaks representing the bound and partially free spin-label components in the 
respective “low-field” and “high-field” regions of EPR spectra, whilst with 7-DOXYL-stearic 
acid (7-DSA) the separated peaks were smoothed into one wide peak. 
 
Spin-labelled fatty acid, an excellent substrate- 
 
Spin-labelled fatty acid (SLFA) is an excellent substrate to study binding and fatty 
acid cycling via the lipid bilayer in a protonated form, with competing substrates and ligands 
of UCP. The use of spin-labelled fatty acids gives some insight about the protein, one being 
the affirmative proof of binding site for the fatty acid in the protein, and an other the 
competitive effects of different kinds of fatty acids. As we know that fatty acids are classified 
into active saturated and unsaturated fatty acids and inactive fatty acids. Competition studies 
with some of these fatty acids on UCP bound to SLFA reveal some information on the 
regulation and mechanism of the protein. Standardization of the protein/lipid ratio was one of 
the most important aspects in our studies in order to achieve a demonstrable bound 
component in the spectrum. 
  
The spectrum of a certain spin-labelled fatty acid bound with protein clearly differs 
from that only in micelles without protein which can be shown by accurate determination of 
the 2Azz parameter. This was on average 45.2 ± 0.6 gauss (n=8) with protein, whereas 4-PPA 
in 0.1% nonaethylene glycol monododecyl ether (C12E9) exhibited a 2Azz of 34.4 gauss. 
Figure 3.1 illustrates the EPR spectrum of 112µM 4-proxyl palmitic acid bound to 28µM 
UCP2 in micelles of C12E9. The spectrum exhibits clearly separated peaks in the low-field and 
high-field regions respectively, the two peaks labelled in each region indicate the existence of 
more or less immobilized spin-labelled fatty acid. Correspondence to the h+1i peak of the 
immobilized spin probe, distinct from the residual h+1m peak of more freely tumbling species 
suggests that the former could reflect the population bound to the protein and the later in 
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micelles. The bound regions of the spectrum were re-recorded at higher signal gain and 
aligned over the spectrum for better visualization. When the same UCP sample was 
precipitated with trichloroacetic acid, the bound signal disappeared. The later figure 3.2 
depicts the spectrum of 5 and 7 doxyl spin-labelled fatty acids bound to protein. The protein 
concentration in our preparation varied on an average range of 25µM to 35µM, depending on 
the yield in our experiments. 
 
 
Fig 3.1: EPR Spectra of 112µM 4-proxyl palmitic acid bound to 28µM UCP2. 
 
The present work gives evidence for the interaction of several spin-labelled fatty acids 
with mitochondrial uncoupling protein. Even if the viscous micellar environment provides 
quite an extensive immobilization to spin-labels in the absence of protein, this lower extent 
immobilization was reflected by peak separation of ~30 gauss with a suppressed high-field 
peak as typical for weakly immobilized nitroxides. UCP2 protein addition caused appearance 
of additional bound components separated by more than 40 gauss which was observed in all 
the three kinds of spin-labels, 7 and 5-DOXYL-stearic acid (DSA) and 4-PROXYL-palmitic 
acid (PPA). Consequently, and after judging of the binding changes, they were evaluated only 
when we observed variations in these peaks, termed h+1i and h-1i according to Marsh et al. 
 
Our screening of several spin-labelled fatty acids with different positions of the 
nitroxyl group with respect to the carboxyl group revealed that it is undoubtedly the carboxyl 
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group which is bound to UCP2, since no immobilization was observed for the label of 16-
DOXYL-stearic acid and 2Azz values for the immobilized spin probes were increasing in the 
order of 7-DSA < 5-DSA < 4-PPA, thus reflecting higher immobilization for a closer 
proximity of the nitroxide group to the carboxyl group. In conclusion, we show that spin-
labelled fatty acids when bound to UCP2 are highly immobilized close to their carboxyl end. 
To show the specificity of the UCP2 binding site on which high immobilization of spin 
probes took place, we have demonstrated competition with few exemplar fatty acids which 
decreased those peaks in the high field region which correspond to the bound component. 
This indicates that such competition proceeded on a protein binding site and not within 
micelles and an additional evidence for physiological function of the protein. 
 
Fig 3.2: a) EPR spectra of 120µM 5-DOXYL stearic acid bound to 30µM UCP2, b) EPR Spectra of 
120µM 7-DOXYL stearic acid bound to 30µM UCP2. 
 
One of the main goals of our studies was to explore the functional mechanism of 
UCP2 which was expected to be the same as of UCP1. This postulation was proved by our 
studies with different spin-labelled fatty acids. The significance in studying the competition 
with different fatty acids lies in showing that UCP2 evidently transports monovalent unipolar 
anions, as does UCP1, and that its role is to dissipate the proton gradient existing between the 
mitochondrial matrix and the intermembrane space. 
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It has been known that UCP1 transports monovalent unipolar anions as Cl- (Ježek and 
Garlid, 1990). In order to answer the question how this protein could transport H+ and, in the 
same time Cl-, an involvement of fatty acids (FAs) in the protonophoric function of UCP1 
was proposed (V.P. Skulachev,1991). It was thought that the resulting net transport of protons 
was not because the protein simply translocated protons, but because it was able to mediate 
uniport of anionic fatty acids, while after their passage they became protonated and flipped 
back with the proton (Ježek et al.1997; Jaburek et al. 1999; Jaburek et al. 2001; Zackova et 
al.2003; Ježek et al. 2004; Garlid et al.2005). Thus, it was assumed that fatty acids were the 
proton transporters and that they followed the same pathway as Cl-. 
 
 
Competition of natural fatty acids with spin-labelled fatty acid -  
 
The figure below depicts structures of different saturated and unsaturated fatty acids of 
which some were used for the present study. 
 
 
Fig 3.3: Computationally modelled structures of different fatty acids 
 
 
We have demonstrated the competition of natural fatty acids which displaced the 
bound spin-labelled fatty acid from UCP2. The reason behind studying the same exemplar 
Results and Discussions 39  
substrates with all the spin-labelled probes was to give strong affirmative evidence about the 
presence of a fatty acid binding site on UCP2. 
 
Upon addition of a competing fatty acid to C12E9 micelles, such as dihomo gamma 
linoleic acid i.e. all-cis-8,11,14-eicosatrienoic acid (ETA) or arachidonic acid i.e. all-cis-
5,8,11,14-eicosatetraenoic acid (AA) in increasing concentrations, the bound peaks are 
narrowing and rising in the low-field region, and the double inflection in the high-field region 
turns into a single one. These changes explain that probably arise from the redistribution of 
both fatty acids, the spin probe and the added fatty acid, between the micelles and solution in 
a way that the spin label becomes moving more freely, most probably being released into the 
aqueous medium.  
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Fig 3.4: Illustrates the competition of added eicosatrienoic acid on 5-DSA bound to UCP2. 
 
The competition with palmitic acid (PA) exhibited affinities with slightly higher 
concentrations than that of the spin probe, however the present concentrations of the added 
fatty acids still suggests us the significance in the mechanism of UCP2. In previous studies 
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with UCP1 the reported competition of palmitic acid with 5-DSA on UCP1 showed the 
displacement at the millimolar range. But, still though physiological significance lies in the 
difference from millimolar concentrations to that of micromolar concentrations in the present 
study, it has to be considered that the exact Kd values can’t be estimated. So the Kd values 
mentioned in the tables in the present chapter are an approximate estimation and can be 
referred to as the upper limit of the mean dissociation constant values. 
 
The competition of added fatty acids was more consistent and can be significantly 
observed in case of studies with 4-PPA bound to UCP2. We have demonstrated that a 
competition of 4-PPA with the added fatty acid in the protein free micellar system can only 
redistribute both spin-label and the added fatty acid between detergent micelles and aqueous 
phase, which enables for higher mobility of the spin-probe. Simultaneously, we have also 
shown that in the presence of UCP2 when the spin-label is highly immobilized, the added 
fatty acid causes decrease of the bound peaks due to release from the protein binding site. The 
probe is released to the micellar and aqueous environment which results in raising the 
mobility of the spin-probe in both these phases. This is reflected by the corresponding 
increasing intensity of the h+1m and h-1m peaks respectively.  
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Fig 3.5: Illustrates the competition of eicosatrienoic acid over 4-PPA bound to UCP2. 
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Fig 3.6: Illustrates the competition of arachidonic acid with 4-PPA bound to UCP2. 
 
Arachidonic acid and eicosatrienoic acid, with slightly lower affinities than compared 
with palmitic and oleic acid, exhibited competition in concentrations lower than that of the 
spin probe, which suggest their high affinities to UCP2. In conclusion, by the competition of 
palmitic acid, oleic acid, arachidonic acid and eicosatrienoic acid with 5-DSA and 4-PPA 
bound to UCP2, a putative fatty acid binding site is observed for mitochondrial uncoupling 
protein 2. 
 
Fattyacid used Approx kD 
Eicosatrienoicacid 
Arachidonicacid 
Oleicacid 
60µM 
60µM 
50µM 
 
Table 3.1: The approximate dissociation constants concentration of different fattyacids. 
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 Fig 3.7: Illustrates the competition of oleic acid with 4-PPA bound to UCP2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graph 3.1: Approximate upper limit kD estimation for ETA and OA. 
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Graph 3.2: Approximate upper limit kD estimation of AA. 
 
 
Experiments with brown fat mitochondria in the early 1970s indicated that these 
mitochondria had an atypical permeability to anions at neutral pH. This anion permeability 
was soon related to the nucleotide-sensitive uncoupling pathway that was responsible for the 
thermogenic capacity of the tissue. Ježek and Garlid demonstrated years later that the 
reconstituted UCP1 could catalyze a GDP-sensitive transport of a wider variety of anions. 
These observations have ended up in the proposal that fatty acids are also UCP substrates. 
Therefore, their hypothetical mechanism for the fatty acid activation of thermogenesis would 
be a protonophoric cycle: the translocation of the anionic form of the fatty acid. Once in the 
cytosolic side of the membrane, the carboxylate group would pick up a proton and the 
protonated fatty acid would flip-flop back to the matrix side where the proton would be 
released and the protonophoric cycle is completed. 
 
 
Alkyl sulfonates as competitors for UCP2 –  
 
The requirements of the transported substrates do not appear to be very stringent when 
analyzed with UCP reconstituted in liposomes. They must be monovalent anions, and a 
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second polar group cannot be present unless it is close to the carboxylate. It has also been 
described that increasing hydrophobicity also increases the rate of permeation. One intriguing 
limitation to the transmembrane flip-flop is the presence of bulky-planar structure of the 
benzene ring at the end of the tail and thus, a compound like phenyl-hexanoic acid does not 
permeate so easily. 
 
Alkylsulfonates constitute an interesting group of substrates or competitors to UCP 
because of their resemblance to fatty acids but with a pKa for the sulfonic group being much 
lower than that of the carboxylate. Long-chain alkylsulfonates have been considered as 
fundamental proofs of the fatty acid cycling mechanism. However, since the pKa of the 
sulfonic group is too acidic, it cannot be protonated at physiological pH and therefore it 
cannot flip-flop to allow the transbilayer movement of the proton. This is supported by 
findings for the first time in respiring BAT mitochondria, concerning the activation of 
respiration by undecanesulfonate (UDS) E.Rail et al (2004). 
 
The results of competition with alkylsulfonates on UCP2 bound to spin-labelled fatty 
acid have a clear interpretation. If alkylsulfonate is unable to flip-flop and it can activate 
respiration in a nucleotide-sensitive manner, then the protonophoric cycle cannot be the 
underlying mechanism of the uncoupling mediated by UCP2. There is another hypothetical 
mechanism, the “proton buffering model” that proposes that the fatty acid acts as prosthetic 
group. The carboxylate would bind protons and deliver them to a site from which they are 
translocated to the other side of the membrane. Alkylsulfonates and fatty acids would provide 
a group that would be part of the translocation pathway. Although the pKa of an acid group 
can change significantly depending on the protein environment, it is possible that the pKa of 
the sulfonic group may be too low to be readily protonable at physiological pH. If this were to 
be the case, these anionic molecules could act by altering the carrier conformation and 
transport properties so that protons could overcome the nucleotide inhibition. None of these 
two possibilities can be dismissed at present. Our results confirm the existence of a binding 
site for fatty acids on UCP and show that this binding site is identical, at least with a part of 
the anion channel. The strong evidence for this is provided by the competition of known UCP 
substrates. Since fatty acids were reported to inhibit alkylsulfonate uniport, the competition of 
alkylsulfonates and fatty acids is mutual. All our data give further support to the earlier 
evaluation of the transport mechanism of UCP. 
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Fig 3.8: Competition of undecane sulfonate with UCP2 bound to 7DSA 
 
Electrophoretic proton flux is the sine qua non of an uncoupling function. Our data 
gives evidence to agree with this primary criterion, thereby establishing them as uncoupling 
proteins in function as well as name. Indeed, the transport properties of UCP2 are 
qualitatively identical with those of UCP1 with respect to transport of protons and 
alkylsulfonates. The finding that fatty acids are obligatory for proton flux mediated by UCP2, 
just as they are for UCP1 has important implications for the biophysical transport mechanism 
of uncoupling proteins, an issue that is not entirely resolved. 
3400 3420 3440 3460 3480 3500
-14000
-12000
-10000
-8000
-6000
-4000
-2000
0
2000
4000
6000
8000
 
 
Field [G]
 SLFA + Ptn (C)
 C + 1.5mM UDS
 C + 2.3mM UDS
 C + 3.1mM UDS
Results and Discussions 46  
0 500 1000 1500 2000
-18000
-16000
-14000
-12000
-10000
-8000
-6000
-4000
-2000
0
2000
4000
6000
8000
 
 
Field [G]
 SLFA + Ptn (C)
 C + 2.3mM ODS
 C + 2.9mM ODS
 C + 3.5mM ODS
 C + 3.9mM ODS
Fig 3.9: Competition of octadecane sulfonate with UCP2 bound to 7DSA 
 
We favour the fatty acid protonophore model, shown in Fig:1.2, according to which 
uncoupling proteins contain a transport pathway for the anionic head groups of fatty acid and 
also probably for alkylsulfonates. The head group is driven from one membrane leaflet to the 
other by the electric field generated by electron transport. When the fatty acid carboxylate 
reaches one side, it picks up a proton and rapidly flip-flops back to release the proton to the 
outer side. The uncoupling proteins thus catalyze a protonophoretic cycle, leading to 
uncoupling of oxidative phosphorylation. 
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Fig 3.10: Competition of octadecane sulfonate with 4PPA bound to UCP2. 
 
An alternative model by Klingenberg and co-workers proposes that UCP1 transports 
protons, that the transport pathway contains histidines, and that fatty acids function as 
nonstoichometric cofactors to buffer intrachannel protons. In a major advance, Bienengraeber 
et al.(1998) demonstrated that substitution of two histidines (H145Q, H147N) in UCP1 
caused selective loss of H+ transport and concluded that these histidines constitute part of the 
proton conducting pathway. The authors go on to predict that UCP2, which contains neither 
histidine, will not conduct protons and that UCP3, which contains only one histidine will 
conduct protons only weakly. In our view, the mutagenesis results are equally consistent with 
the fatty acid protonophore model and suggest that the histidines in UCP1 form part of the 
binding site in the fatty acid anion transport pathway. UCP2 and UCP3 possess ample basic 
residues in this region to fulfil such role (Ježek et al. 1998). Our interpretation therefore 
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predicts that UCP2 and UCP3 will catalyze fatty acid dependent proton transport, and our 
results with UCP2 thus provide independent support for the postulated fatty acid 
protonophore model. 
 
Transport of the head group alkylsulfonates also supports the fatty acid protonophore 
model. In the present study the competition with undecanesulfonate and octadecanesulfonate 
which are close analogues to laurate and arachidate. Undecanesulfonate is known as 
competitive inhibitor of laurate induced H+ transport in UCP1. The sulfonate group is 
transported across the membrane by both the uncoupling proteins 1 and 2; however, 
alkylsulfonates do not support H+ transport. Thus, alkylsulfonates share the anion transport 
pathway in uncoupling protein with fatty acid, but they cannot complete the protonophoretic 
cycle. The reason for this failure already discussed in the present chapter being that sulfonates 
are strong acids and, consequently, cannot deliver protons by electroneutral flip-flop across 
the bilayer. The fact that the anionic head group of alkylsulfonates is transported across the 
membrane is a serious problem for the buffering model, because there is no known 
physicochemical mechanism that would permit alkylsulfonate anion transport and 
prohibit/inhibit fatty acid anion transport. 
 
Role of UCP2 in down-regulation of reactive oxygen species production -  
 
Any slight increase of the H+ back flux (to the matrix), which diminishes proton 
motive force (∆p), results in a substantial decrease of mitochondrial ROS formation. It can be 
explained on the basis of increased respiration due to the respiratory control. Slightly 
increased respiration shortens lifetime of ubisemiquinone radical (UQ·) and leads to lowered 
oxygen tension in the micro environment. Both processes cause reduced rate of O2-· 
formation. Naturally such an increased H+ backflow proceeds via the Fo part of ATP-
synthase. Hence also during the transition between state 4 (non-phosphorylating resting 
respiration) to state 3 (ATP synthesis) ROS formation is drastically reduced. In other words, 
most of ROS are produced in vivo under the non-phosphorylating “resting” state. The H+ 
backflow given by uncoupling (i.e. by leak or protein-mediated uncoupling) accordingly also 
decreased the rate of ROS formation rate. Consequently, even the mild uncoupling given by 
UCP2 (or UCP3 to UCP5), when activated by fatty acids and by releasing purine nucleotide 
inhibition, can intensively down-regulate ROS production (Nègre-Salvayre et al. 1997, 
Arsenijevic et al. 2000).  
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Downregulation of mitochondrial reactive oxygen species (ROS) production seems to 
be the most plausible role for UCP2, since its expression is expected in numerous mammal 
tissues, yet in minute amounts though. The same considerations are valid for UCP3 in skeletal 
muscle and UCP4 and UCP5 in the brain. Thus the report of Nègre-Salvayre et al. could be 
interpreted as suppression of ROS production due to the UCP2 function. They observed an 
increased H2O2 production due to membrane potential (∆ψ) increase induced by GDP 
addition, likely mediated by UCP2 in macrophage (liver Kupffer cell) mitochondria or in 
thymus and spleen mitochondria. Also, the UCP2(-/-) and UCP3(-/-) mice exhibited higher 
levels of ROS in macrophages and muscle, respectively.  
 
Moreover, Brand’s group (Echtay et al. 2002) promoted the idea that superoxide itself 
activates UCP2 by unspecified mechanism from the matrix side. Recently, they rather 
ascribed such ability to the end-product of the lipoperoxidation cascade for ω-6 
polyunsaturated fatty acids (PUFAs), to 4-hydroxy-2-nonenal. In addition, Skulachev and 
Goglia (2003) speculated that fatty acid hydroperoxides can be anionic transport substrates of 
UCPs, but predicted that they cannot diffuse through the membrane in a protonated form. This 
speculation was indeed true and proved by our studies with the inability of competition by the 
added 12-hydroxy-lauric acid (HLA) and 4-hydroxy-2-nonenal (HNE) even at concentrations 
much higher than the spin label fatty acid. Activation of UCP2 mediated uncoupling by fatty 
acid hydroperoxides could provide a feedback control mechanism by which the 
lipoperoxidation product and hence also the product of the increased ROS production activate 
uncoupling. Thus, this leads to the suppression of ROS production. Similarly, the activation 
of UCP2 by superoxide proposed by Brand’s group could be in fact activation by 
lipoperoxidation products such as fatty acid hydroperoxides and hydroxy fatty acids, formed 
downstream in the ROS propagation cascade. 
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Fig 3.11: Illustrates the inactivity of hydroxy fatty acids to displace the bound 4-PPA(112µM) to 
UCP2(28µM) (HLA: 12-hydroxy lauric acid, HNE: 4-hydroxy -2-nonenal.) 
 
 Effect of purine nucleotides on spin-labelled fatty acid binding to the UCP –  
 
Addition of the native ligand ATP to the spin-labelled fatty acid bound to UCP2 
strongly affected this complex which can be clearly seen in the EPR spectra. The changes in 
the EPR spectra with increasing ATP concentrations were less complicated than those 
described earlier for alkyl sulfonates and fatty acids. With increasing nucleotide amounts the 
h+1i peak decreased and gradually smoothed into a single narrow peak. Alkaline pH, which is 
known to reduce nucleotide binding as demonstrated by Klingenberg, reversed this effect of 
ATP on spin label binding in such a way that the original bound spectrum reappeared. UCP2 
labelled with spin-labelled fatty acid was inhibited upon addition of ATP of particular 
concentration with pH 7.0, and at alkaline pH the spectra changed back to the “bound” 
original form. 
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Fig 3.12:  a) (-) Illustrates ESR spectra of 100µM 7-DSA bound to 24µM UCP2, (-) upon addition of 
5mM ATP at neutral pH, (-) upon increasing it to alkaline pH. b) The same titration as above but 
depicts the clear spectral-shape changes in the low and high-filed region. 
 
 
However we now demonstrate that the spectral changes rather indicate a loss of 
binding. Under conditions when ATP binding is weak, i.e. at alkaline pH, the spectral changes 
are reversed to the original bound spectrum. Certain spin-labelled fatty acids embedded in 
short chain phospholipids and with the nitroxyl group closer to the terminal methyl group 
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have been reported to give similar spectral changes i.e. larger 2Azz values at high pH. 
Protonation of the carboxyl group here leads to deeper insertion into the membrane, and 
deprotonation reverses this effect. In our system of a long chain detergent, such an effect 
should not occur as proven by experiments in the absence of protein. Hence we conclude that 
ATP causes partial displacement of bound spin-label from UCP and the probe rebinds at 
alkaline pH which releases ATP. 
 
Since the influence between ATP and fatty acid is unidirectional, and GDP is a non-
competitive inhibitor of anion transport by UCP, we can conclude that the displacement of 
spin-labelled fatty acid by ATP is allosteric. This displacement mimics the inherent molecular 
mechanism of gating. Probably, conformational changes switched by ATP prevent exposure 
of those residues which are essential for binding of anionic substrates. They cause the 
inaccessibility of the internal anion binding site for anions. The existence of the internal 
binding site has been suggested previously because of the lack of an external binding site for 
substrates of UCP, the increasing affinity of more hydrophobic substrates to UCP, and the 
two-energy barrier profile derived from the flux voltage characteristics. 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.13: Illustrates the effect of ATP alkaline pH on 4-PPA bound to UCP2 
 
Inhibition by purine nucleotides is also an essential property of UCP1. Since fatty 
acids have no effect on the Ki for nucleotide inhibition, it is generally agreed that transport and 
inhibition take place on different domains. The nucleotide binding domain in UCP1 is 
extensive and reasonably well characterized. The sugar base moiety binds to three residues 
located on the peptide segment that connects helices 5 and 6, an interaction that may confer 
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selectivity among nucleotides. A glutamate (Glu190) in the fourth transmembrane helix is the 
pH sensor for nucleotide binding. Three arginines, located in the helices 2, 4, and 6, are 
required for nucleotide mediated inhibition and have been shown to bind nucleoside 
phosphates (Modrianský, M et al. 1997). Site-directed mutagenesis studies have led to a 
three-stage binding conformational change model for nucleotide binding and inhibition in 
UCP1. 
 
It is noteworthy that the seven residues involved in nucleotide mediated inhibition are 
largely conserved in UCP2, suggesting not only that these proteins would be regulated by 
nucleotides but also that regulation would be similar among the UCPs. Surprisingly, there are 
striking differences in nucleotide sensitivity among the UCPs, with UCP2 and UCP3 being 
only weakly sensitive to GDP, for example. The physiological significance of variations in 
nucleotide inhibition is unclear, because it is not known how any of the UCPs are opened in 
vivo. In the case of UCP1, a common view is that uncoupling is initiated by dissociation of 
ATP. In our view, nucleotide debinding is an unlikely opening mechanism: to regulate 
important physiological processes, nature normally relies on specific signalling pathways and 
not on the law of mass action. Regulation may involve post-translational modification of the 
proteins; however, no such signalling pathway has yet been demonstrated in the opening of 
any of the UCPs. 
 
 
 
 
 
 
 
 
Fig 3.14: Model for the molecular mechanism of gating by nucleotides in UCP. 
 
A major value of studies such as these on isolated, reconstituted UCP2 is that this 
permits direct comparison with similar studies obtained using UCP1. In this regard, our most 
noteworthy finding is that both the mammalian UCPs are qualitatively identical in mediating 
fatty acid dependent proton transport. This gives a conclusion and suggestion on future 
approach, or studies on whole cells and isolated mitochondria containing native UCP are 
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urgently needed to advance the field. It is hoped that the biophysical approach described here 
will prove as a useful guide to study on the native system.
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SUMMARY 
 
Uncoupling protein1 (UCP1) in brown adipose tissue was discovered earlier as the 
main uncoupling source of respiration. We describe the basic facts and a modest contribution 
of our group to the area of research on mitochondrial uncoupling proteins. After defining the 
terms uncoupling, leak, proton-mediated uncoupling, we discuss the assumption that due to its 
low abundance, uncoupling protein 2 (UCP2) can provide only mild uncoupling, i.e. can 
decrease the proton motive force by several mV only. A fatty acid cycling mechanism is 
described as a plausible explanation for the protonophoretic function of all uncoupling 
proteins together with our experiments supporting it. A speculation for the phylogenesis of all 
uncoupling proteins can be deduced by estimated UCP2 content in several tissues, and details 
of its activation are explained on the basis of our experiments. In the present study a 
solubilization and refolding method for UCP2 from inclusion bodies was developed and 
characterized. As it was known and also demonstrated from previous experiments on UCP1 
that fatty acids are substrates, we used the same procedure to study the function of UCP2. 
Utilizing spin-labelled fatty acids (SLFA) for our experiments we demonstrated the binding of 
fatty acids to UCP2, and the competition of other natural fatty acids like oleic acid, palmitic 
acid, arachidonic acid and eicosatrienoic acid to the preformed complex emphasizes the 
presence of a fatty acid binding site for mitochondrial UCP2. The findings were observed by 
EPR spectroscopy where the highly immobilized spectra with presence of spin-labelled fatty 
acid eventually end up as free spin label spectra with a particular concentration of the natural 
fatty acid added to the UCP2 bound with spin-labelled fatty acid. This fits in significantly 
with the earlier findings of UCP1 and also leads to assumption of functional explanation 
about the physiological relevance between the uncoupling proteins functions. The present 
study, in which representative and sensitive parameters for EPR spectroscopy were 
established, at the same time describes the concentration effects of fatty acids upon the protein 
bound with spin-labelled fatty acids which are much of importance in comparison to 
physiological levels, being in the micromolar range (µM) as compared with milli molar (mM) 
as for UCP1 previously. 
 
In appropriate examples, different fatty acids are used and compared with competitors 
like alkylsulfonates also emphasizing the function of the protein. And the studies with the 
effect of nucleotides inhibition demonstrate that there exists a putative binding site for fatty 
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acids. Much significance lies in demonstration with the spin-labelled-ATP studies where 
competition of ATP to the protein bound to spin-labelled ATP explains about the inhibition 
effect of nucleotides on the UCP2. So the present study applies different methods for the 
functional characterization of UCP2. The studies of natural fatty acids and alkylsulfonates 
with UCP2 bound to spin-labelled fatty acid, and study of nucleotide inhibition on UCP2 are 
closely related and give the much awaited answer to the question of functional similarities 
between UCP1 and UCP2. This supports the discussion of many groups which predict the 
functional similarity between these two proteins based upon sequence homology. Also many 
attempts have been reported in literature to explain the physiological functional relevance 
where by this present study can also be added to as we now suppose from the present 
conclusions of our experiments. 
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ZUSAMMENFASSUNG 
 
Entkoppler-Protein 1 (uncoupling protein 1, UCP1) wurde bereits früher als 
Hauptursache der Atmungs-Entkopplung in braunem Fettgewebe entdeckt. Wir beschreiben 
hier die grundlegenden Tatsachen sowie unseren Beitrag zur Erforschung der mitochondrialen 
Entkoppler-Proteine. Nach einer Definition der Begriffe Entkopplung, Leck (leak) und 
Protonen-vermittelte Entkopplung, diskutieren wir die Annahme, dass Entkoppler-Protein 2 
(UCP2) auf Grund seines geringeren Vorkommens nur schwache entkoppelnde Wirkung 
zeigen, d. h. die protonmotorische Kraft nur um wenige mV senken kann. Ein Fettsäure-
Austausch-Mechanismus wird als plausible Erklärung für die Protonentransport-Funktion 
aller Entkoppler-Proteine beschrieben, der durch unsere Ergebnisse unterstützt wird. Eine 
Spekulation über die Phylogenese aller Entkoppler-Proteine kann durch Abschätzung des 
UCP2-Gehalts in verschiedenen Geweben abgeleitet werden, und Einzelheiten der 
Aktivierung können auf Grund unserer Experimente erklärt werden. In der vorliegenden 
Arbeit wurde eine Solubilisierungs- und Rückfaltungsmethode für UCP2 aus inclusion bodies 
entwickelt und charakterisiert. Da aus früheren Experimenten mit UCP1 bekannt war, dass 
Fettsäuren als Substrate fungieren, benutzten wir beim Studium der Funktion von UCP2 
dieselbe Vorgehensweise wie dort. Unter Verwendung von spinmarkierten (spin-label-, SL-
)Fettsäuren für unsere Experimente demonstrierten wir die Bindung von Fettsäuren an UCP2, 
und die Konkurrenzreaktion natürlicher Fettsäuren wie Ölsäure, Palmitinsäure, 
Arachidonsäure und Icosatriensäure am vorgeformten Komplex unterstreicht das 
Vorhandensein einer Fettsäure-Bindungstasche bei mitochondrialem UCP2. Die 
Beobachtungen wurden mit Hilfe von EPR-Spektroskopie gemacht, wobei zunächst bei 
Zugabe von SL-Fettsäure zu UCP2 Spektren erhalten werden, die für hohe Immobilisierung 
typisch sind, die aber bei Zugabe bestimmter Konzentrationen natürlicher Fettsäuren in die 
Spektren der freien SL-Fettsäure übergehen. Dies passt bedeutsamerweise zu den früheren 
Ergebnissen mit UCP1 und führt auch zu einer Annahme über die physiologische Relevanz 
der Funktionen der Entkoppler-Proteine. Die vorliegende Studie, in der repräsentative und 
sinnvolle Parameter für die EPR-Spektroskopie erarbeitet wurden, beschreibt zugleich 
Konzentrationseffekte von Fettsäuren auf den Komplex von Protein und SL-Fettsäure, die 
auch im Hinblick auf physiologische Konzentrationen durchaus Bedeutung haben, da sie im 
mikromolaren Bereich auftreten im Gegensatz zum millimolaren zuvor bei UCP1. 
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Eine geeignete Auswahl verschiedener Fettsäuren wurde als Kompetitoren benutzt und 
in dieser Eigenschaft mit Alkylsulfonaten verglichen, wodurch ebenfalls die Funktion des 
Proteins deutlich gemacht wurde. Untersuchungen des Effekts der Inhibierung durch 
Nucleotide zeigen ebenfalls die Existenz der fraglichen Fettsäure-Bindungstasche. Große 
Bedeutung liegt in der Demonstration der Verdrängung von SL-ATP durch ATP aus dem 
Komplex mit dem Protein, wodurch der inhibitorische Effekt von Nucleotiden auf UCP2 
erklärt wird. Hierzu werden in der vorliegenden Arbeit verschiedene Methoden zur 
funktionellen Charakterisierung von UCP1 angewandt. Die Untersuchungen natürlicher 
Fettsäuren und Alkylsulfonate mit UCP2 im Komplex mit spinmarkierter Fettsäure und die 
Untersuchung der Nucleotid-Inhibition von UCP2 hängen eng zusammen und geben die lang 
erwartete Antwort auf die Frage nach funktionellen Ähnlichkeiten bei UCP1 und UCP2. Dies 
stellt die Diskussionen vieler Gruppen auf eine neue Grundlage, die die funktionelle 
Ähnlichkeit beider Proteine auf Basis der Sequenzhomologie vorhersagen. Es gab auch viele 
Versuche in der Literatur, die physiologische Relevanz aufzuklären, wozu durch diese 
Untersuchungen, nach unseren gegenwärtigen Experimenten zu schließen, ebenfalls ein 
Beitrag geleistet werden kann. 
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